Earnings Feed
Start Free
Home/Filings/4/0000899243-21-022899
4//SEC Filing

Stimart Tryn 4

Accession 0000899243-21-022899

CIK 0001703057other
View on SEC.govCompany Profile

Filed

Jun 8, 8:00 PM ET

Accepted

Jun 9, 8:30 PM ET

Size

12.5 KB

Accession

0000899243-21-022899

Insider Transaction Report

Form 4
Period: 2021-06-07
AbCellera Biologics Inc.ABCL
Stimart Tryn
Chief Legal Officer
Transactions
  • Exercise/Conversion

    Share Option (right to buy)

    2021-06-07−750,000→ 1,250,000 total
    Exercise: $0.32Exp: 2029-08-22→ Common Shares (750,000 underlying)
  • Exercise/Conversion

    Share Option (right to buy)

    2021-06-07−250,000→ 600,000 total
    Exercise: $2.30Exp: 2030-10-29→ Common Shares (250,000 underlying)
  • Exercise/Conversion

    Common Shares

    2021-06-07$2.30/sh+250,000$575,000→ 1,000,250 total
  • Exercise/Conversion

    Common Shares

    2021-06-07$0.32/sh+750,000$240,000→ 750,250 total
Holdings

  • Common Shares

    (indirect: By Spouse)
    250
Footnotes (3)
  • [F1]Previously reported on Form 3 filed on December 11, 2020. The vesting schedule was amended as follow: 25% of the shares subject to such option vest and become exercisable on August 22, 2020; 6.25% of the shares subject to such option vest and become exercisable on November 22, 2020 and February 22, 2021; 4.70% of the shares subject to such option vest and become exercisable on on July 1, 2022; 8.9% of the shares subject to such option vest and become exercisable on October 1, 2022; 7.4% of the shares subject to such option vest and become exercisable on January 1, 2023; 10.40% of the shares subject to such option vest and become exercisable on April 1, 2023; 8.90% of the shares subject to such option vest and become exercisable on July 1, 2023 and October 1, 2023; 2.70% of the shares subject to such option vest and become exercisable on January 1, 2024;
  • [F2](Continued from footnote 1) and 2.65% of the shares subject to such option vest and become exercisable on April 1, 2024, July 1, 2024, October 1, 2024 and January 1, 2025.
  • [F3]Previously reported on Form 3 filed on December 11, 2020 and Form 4 filed on December 17, 2020. The vesting schedule was amended such that all of the shares subject to such option were vested as of March 24, 2021.

Documents

1 file

Issuer

AbCellera Biologics Inc.

CIK 0001703057

→
Entity typeother

Related Parties

1
  • filerCIK 0001834424

Filing Metadata

Form type
4
Filed
Jun 8, 8:00 PM ET
Accepted
Jun 9, 8:30 PM ET
Size
12.5 KB
View on SEC.gov